Spectrofluorometric resolution of closely overlapping drug mixtures using chemometrics methods

Multivariate methods on the excitation emission matrix fluorescence spectroscopic data of diesel–kerosene mixtures: A comparative study

Quantitative determination of kerosene fraction present in diesel has been carried out based on excitation emission matrix fluorescence (EEMF) along with parallel factor analysis (PARAFAC) and N-way partial least squares regression (N-PLS). EEMF is a simple, sensitive and nondestructive method suitable for the analysis of multifluorophoric mixtures. Calibration models consisting of varying compositions of diesel and kerosene were constructed and their validation was carried out using leave-one-out cross validation method. The accuracy of the model was evaluated through the root mean square error of prediction (RMSEP) for the PARAFAC, N-PLS and unfold PLS methods. N-PLS was found to be a better method compared to PARAFAC and unfold PLS method because of its low RMSEP values.

Simultaneous Fluorometric Resolution of Pyridoxal, Pyridoxamine and 4-Pyridoxic Acid Using Chemometric Methods

An alternatively minimizing covariant matrix error (AMCME) algorithm, newly proposed by the present authors, was applied to the simultaneous fluorometric determination of pyridoxal, pyridoxamine and 4-pyridoxic acid without loss of sensitivity. The experimental results illustrate that the profiles of spectra and concentration can be accurately resolved using the AMCME algorithm with a high sensitivity and stable repeatability. That is to say, the closely overlapping problem of the spectra could be resolved owing to the characteristic features of the AMCME algorithm.

Second-order calibration of excitation-emission matrix fluorescence spectra for the determination of N-phenylanthranilic acid derivatives

A spectrofluorimetric method has been developed for the quantitative determination of mefenamic, flufenamic, and meclofenamic acids in urine samples. The method is based on second-order data multivariate calibration (unfolded partial least squares (unfolded-PLS), multi-way PLS (N-PLS), parallel factor analysis (PARAFAC), self-weighted alternating trilinear decomposition (SWATLD), and bilinear least squares (BLLS)). The analytes were extracted from the urine samples in chloroform prior to the determination. The chloroform extraction was optimized for each analyte, studying the agitation time and the extraction pH, and the optimum values were 10 minutes and pH 3.5, respectively. The concentration ranges in chloroform solution of each of the analytes, used to construct the calibration matrix, were selected in the ranges from 0.15 to 0.8 microg mL-1 for flufenamic and meclofenamic acids and from 0.25 to 3.0 microg mL-1 for mefenamic acid. The combination of chloroform extraction and second-order calibration methods, using the excitation-emission matrices (EEMs) of the three analytes as analytical signals, allowed their simultaneous determination in human urine samples, in the range of approximately 80 mg L-1 to 250 mg L-1, with satisfactory results for all the assayed methods. Improved results over unfolded-PLS and N-PLS were found with PARAFAC, SWATLD, and BLLS, methods that exploit the second-order advantage.

Evaluation of partial least-squares with second-order advantage for the multi-way spectroscopic analysis of complex biological samples in the presence of analyte–background interactions

The combination of unfolded partial least-squares (U-PLS) with residual bilinearization (RBL) has not been properly exploited to process experimental second-order spectroscopic information, although it is able to achieve the important second-order advantage. Among other desirable properties, the technique can handle incomplete calibration information, i.e., when only certain analyte concentrations are known in the training set. It can also cope with analyte spectral changes from sample to sample, due to its latent variable structure. In this work, U-PLS/RBL has been successfully applied to experimental fluorescence excitation-emission matrix data aimed at the quantitation of analytes in complex samples: these were the antibiotic tetracycline and the anti-inflammatory salicylate, in both cases in the presence of human serum, where significant analyte-background interactions occur. The interactions of the analyte with the serum proteins modify their spectral fluorescence properties, making it necessary to employ training sets of samples where the biological background is present, possibly causing analyte spectral changes from sample to sample. The predictive ability of the studied model has been compared with that of parallel factor analysis (PARAFAC), as regards test samples containing different sera, and also other pharmaceuticals which could act as potential interferents.